Blog

882 Articles

Magnified slide of human pancreas cells, stained in aqua color with a dark outline around some of the rounded cells
Research
July 24, 2017 • 2 Min

Trying a New Type of Treatment to Stop Advanced Pancreatic Cancer

Researchers test the chemotherapy combination of AM0010 and FOLFOX as a second-line therapy for people with metastatic pancreatic cancer.

Pancreatic cancer patient Irwin Greenblatt and his wife Audrey
Survivor Stories
July 19, 2017 • 5 Min

Hope and a Chance to Fight

Irwin Greenblatt just wanted a chance, so after Whipple surgery he agreed to join a chemotherapy clinical trial. His wife Audrey tells their story.

Dr. Luis Diaz
Research
July 14, 2017 • 5 Min

An Immunotherapy Game Changer

Immunotherapy with Keytruda (pembrolizumab) is approved for use in cancer patients with certain genetic defects in their tumors.

Glass flasks with wider bottoms and narrower tops sit on a table; the left flask is partway filled with dark green clear liquid, the right flask contains a lighter bright green clear liquid
Research
July 11, 2017 • 2 Min

Testing the Safety of a New Chemotherapy and Radiation Combination

A clinical trial tests the effectiveness of adding PEGPH20 to standard chemotherapy and radiation in patients with locally advanced pancreatic cancer.

pancreatic cancer patient Barry Reiter
Survivor Stories
July 6, 2017 • 3 Min

Pancreatic Cancer Found By Chance

Barry Reiter’s pancreatic cancer was found during a presurgical MRI for prostate cancer. Now he had a bigger battle on his hands.

Petri dishes
Research
July 3, 2017 • 3 Min

Predicting Effective Therapy in Pancreatic Cancer

Dr. Kenneth Yu is leading a clinical trial that looks at a pancreatic cancer patient’s pharmacogenomic profile, to see which chemotherapy works better.

Illustration of a protein that includes the BRCA2 mutation. The illustration includes spirals in brown, strands in purple, blue directional arrows, and green, yellow, red, and blue circles.
Research
June 27, 2017 • 2 Min

A Maintenance Trial for Patients with BRCA or PALB2 Mutations

A clinical trial examines whether the PARP inhibitor rucaparib can work as a maintenance drug for pancreatic cancer patients with BRCA or PALB2 mutations.

Dr. Margaret Tempero
Research
June 23, 2017 • 4 Min

Targeted Therapy for Pancreatic Cancer

Dr. Margaret Tempero outlines the work being done in the area of targeted therapy for pancreatic cancer, specifically the testing of ibrutinib.

pancreatic cancer patient Leslie Wineberg
Survivor Stories
June 20, 2017 • 4 Min

The Relatively New Procedure of Irreversible Electroporation Has Given Me Time

When chemotherapy and radiation stopped working, Leslie Wineberg was glad to qualify for irreversible electroporation (IRE).

abstract image of stem cells with a large area of red, interspersed with blue, and bright green areas at the bottom of the image
Research
June 15, 2017 • 2 Min

Adding a New Drug to Standard Treatment for Metastatic Pancreatic Cancer

A clinical trial tests the effectiveness of napabucasin, a drug that affects the signaling pathways of cancer stem cells.

Collage of Clinical Oncology News logo, photo of Dr. Allyson Ocean, and magazines
News
June 13, 2017 • 1 Min

New Crowdsourcing Platform Connects Pancreatic Cancer Patients to the Latest Studies

Dr. Allyson Ocean, a founder of Let’s Win, has a short video that explains how the website uses crowdsourcing of information for pancreatic cancer patients.

Jill Pechacek
Survivor Stories
June 12, 2017 • 6 Min

Fighting On To See Her Children Grow Up

Despite aggressive pancreatic cancer, with a BRCA-like genetic mutation, Dr. Jill Pechacek is determined to stay alive to see her children grow up.

Dr. Joseph Herman
Research
June 7, 2017 • 5 Min

Stereotactic Body Radiation Therapy (SBRT) for Select Pancreatic Cancer Patients

Stereotactic body radiation therapy (SBRT) is increasingly being used to treat locally advanced pancreatic cancer, and make it surgically removable.

Image of DNA analysis showing a series of darker and lighter orange-colored columns with thin horizontal red, yellow, white, and orange stripes indicating different genes
Research
June 2, 2017 • 2 Min

Focusing on a Drug that Treats Specific Tumor Mutations

A clinical trial tests a signal-inhibiting drug for lung cancers with specific genetic mutations on gastrointestinal cancers with the same tumor mutations.

pancreatic cancer survivor Sheila Sky Kasselman
Survivor Stories
May 30, 2017 • 3 Min

Pancreatic Cancer Leads to a New Direction

After Sheila Sky Kasselman recovered from pancreatic cancer treatment, she became a pancreatic cancer activist, determined to help find more treatments.